Literature DB >> 3475268

Ofloxacin and antacids.

F P Maesen, B I Davies, W H Geraedts, C A Sumajow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3475268     DOI： 10.1093/jac/19.6.848

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Antacids and ciprofloxacin pharmacokinetics.

Authors:  W Bianchi; F Maggiolo; A Imbasciati; H K Ohnmeiss
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

3.  Oral absorption of ofloxacin administered together with aluminum.

Authors:  A Sánchez Navarro; M Martínez Cabarga; A Dominguez-Gil Hurlé
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

Review 4.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

Review 5.  Absorption interactions with fluoroquinolones. 1995 update.

Authors:  B M Lomaestro; G R Bailie
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

Review 6.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

7.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.